NCT06110910View on ClinicalTrials.gov

Long-term Efficacy and Safety Evaluation of Growth Hormone in Children in China(CGLS)

RecruitingOBSERVATIONAL
Enrollment

10,000

Participants

Timeline

Start Date

March 1, 2023

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2027

Conditions
Childhood Short Stature
Interventions
DRUG

Polvethylene glycol recombinant human growth hormone injection (PEG-rhGH) or recombinanthuman growth hormone injection (rhGH)

Polvethylene glycol recombinant human growth hormone injection (PEG-rhGH) and recombinanthuman growth hormone injection (rhGH) were used.

Trial Locations (1)

430030

RECRUITING

TongjiHospital, Wuhan

All Listed Sponsors
lead

Xiaoping Luo

OTHER